HEALTH

Study suggests that Americans may not know extent of heart disease risk

BY Michael Johnsen

NORTHRIDGE, Calif. A survey conducted by Harris Interactive and commissioned by Nature Made found that nearly half of all respondents did not know their current cholesterol levels and 20 percent have never had them checked, suggesting that Americans may not be appropriately managing their heart disease risk despite the high awareness around heart disease, Pharmavite, maker of Nature Made, announced Monday.

“Studies show simple lifestyle changes and paying attention to the heart disease risk factors we can control may help Americans live longer, healthier lives,” stated Joseph Keenan, cardiology researcher and professor emeritus, University of Minnesota, who advises people to eliminate risk factors such as smoking or being overweight.

“For some who have high cholesterol due to genetics, following [lifestyle prevention tips may not be enough,” Keenan said. “For these situations, I often recommend a natural ingredient called Pantesin that helps reduce cholesterol production in the liver. Pantesin can be found in … CholestOff Complete, a nutritional supplement from Nature Made.”

The online Heart Health survey was conducted within the United States by Harris Interactive on behalf of Pharmavite between Sept. 4 and 6, 2007 among 2,321 U.S. adults over the age of 18. Results were weighted as needed for age, sex, race/ethnicity, education, region and household income. Propensity score weighting was also used to adjust for respondents’ propensity to be online.

Respondents for this survey were selected from among those who have agreed to participate in Harris Interactive surveys. The data have been weighted to reflect the composition of the U.S. adult population.

Because the sample is based on those who agreed to be invited to participate in the Harris Interactive online research panel, no estimates of theoretical sampling error can be calculated.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?
HEALTH

Allergan appoints Dawn Hudson to board

BY Michael Johnsen

IRVINE, Calif. Allergan on Friday named Dawn Hudson to the company’s board, effective Jan. 28. Hudson is the former president and chief executive officer of Pepsi-Cola North America. In addition, Hudson served as chief executive officer of the PepsiCo foodservice division, which integrated the relevant units of PCNA and Frito-Lay North America with the Quaker, Tropicana and Gatorade brands.

“Hudson’s expertise and insights as a pioneer in brand development and consumer behavior will further strengthen Allergan’s leadership skills in consumer marketing,” stated David Pyott, Allergan’s chairman and chief executive officer. “Building on Allergan’s success record in developing and expanding markets, I am confident Ms. Hudson will add significant value in evaluating innovative practices and channels to help drive greater consumer awareness and appeal for Allergan’s core products.”

Hudson will initially serve as a member of the audit and finance committee and the organization and compensation committee.

Previously, Hudson served as vice chair of the American Beverage Association. She currently sits on the board of Lowe’s home improvement stores and is chairman of the Ladies Professional Golf Association.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?
HEALTH

Hi-Tech sales down due to cough-cold recalls

BY Michael Johnsen

AMITYVILLE, N.Y. Early indications of the industrywide voluntary recall of children’s cough-cold medicines marketed for infants under the age of 2 are negative as it pertains to retail sales, as another cough-cold distributor pointed to the recall as a significant factor behind a companywide decline in sales.

For the three months ended Oct. 31, Hi-Tech Pharmacal reported net sales of $15.9 million, a decrease of 2 percent as compared with the same period last year. Sales for the healthcare products division, which markets the company’s OTC branded products, decreased 38 percent to $2.3 million, largely due to the discontinuation of the children’s formula of Diabetic Tussin at certain retailers.

“We believe the balance of the year will show growth as our core diabetic products continue to do well, and we prepare to introduce several exciting new products in the balance of the fiscal year,” stated Hi-Tech president and chief executive officer David Seltzer.

Last month, Prestige Brands reported its second-quarter results were negatively impacted in part by the voluntary removal of two kids cough-cold products under the Little Remedies banner.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?